A reduction in tumor volume exceeding 65% predicts a good histological response to neoadjuvant chemotherapy in patients with Ewing sarcoma-Reference-Cited by-同舟云学术

A reduction in tumor volume exceeding 65% predicts a good histological response to neoadjuvant chemotherapy in patients with Ewing sarcoma

Published:2024-05-07 Issue: Volume: Page:
ISSN:0364-2348
Container-title:Skeletal Radiology
language:en
Short-container-title:Skeletal Radiol

Author:

Aso Ayano,Aiba Hisaki,Traversari Matteo,Righi Alberto,Gambarotti Marco,Atherley O’Meally Ahmed,Solou Konstantina,Cammelli Silvia,Bordini Barbara,Cosentino Monica,Zuccheri Federica,Dozza Barbara,Frega Giorgio,Ibrahim Toni,Manfrini Marco,Donati Davide Maria,Errani Costantino

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00256-024-04702-7.pdf

Reference34 articles.

1. Grünewald TGP, Cidre-Aranaz F, Surdez D, Tomazou EM, de Álava E, Kovar H, et al. Ewing sarcoma. Nat Rev Dis Primers. 2018;4(1):5.

2. Haveman LM, Ranft A, Vd Berg H, Smets A, Kruseova J, Ladenstein R, et al. The relation of radiological tumor volume response to histological response and outcome in patients with localized Ewing sarcoma. Cancer Med. 2019;8(3):1086–94.

3. Bosma SE, Ayu O, Fiocco M, Gelderblom H, Dijkstra PDS. Prognostic factors for survival in Ewing sarcoma: a systematic review. Surg Oncol. 2018;27(4):603–10.

4. Oberlin O, Deley MC, Bui BN, Gentet JC, Philip T, Terrier P, et al. Prognostic factors in localized Ewing’s tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study). Br J Cancer. 2001;85(11):1646–54.

5. Gaspar N, Rey A, Bérard PM, Michon J, Gentet JC, Tabone MD, et al. Risk adapted chemotherapy for localised Ewing’s sarcoma of bone: the French EW93 study. Eur J Cancer. 2012;48(9):1376–85.